Logo

Leiden Medical Center Installs Bruker Mass Spec Tools

Jan 27, 2009

NEW YORK (GenomeWeb News) — Bruker Daltonics said today that Leiden University Medical Center in the Netherlands has installed two of the company's FTMS systems for use in its proteomics research.

Leiden's researchers will use the company's 12 Tesla and 15 Tesla FTMS systems in protein characterization and analysis studies, Bruker said.

"In the last few years, the LUMC has invested significantly in creating a state-of-the-art proteomics infrastructure," and the new Bruker systems will enable more "in-depth characterization and quantitative analysis of the large number of sample generally encountered in clinical studies," Leiden researcher Andre Deelder said in a statement.

LUMC is conducting studies of proteomes and metabolomes of different body fluids from various patient cohorts in "bottom-up proteomics" studies.

Filed under

Proteomics & Protein Research
proteomics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.